跳至主要内容
临床试验/ACTRN12612001249842
ACTRN12612001249842进行中(未招募)2 期

For patients with anaemia admitted to the Intensive Care Unit, does intravenous iron compared with placebo reduce red blood cell transfusion requirement?

Edward Litton0 个研究点目标入组 140 人开始时间: 2012年11月26日最近更新:

试验速览

阶段
2 期
状态
进行中(未招募)
发起方
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1.Admitted to an ICU for less than 48 hours
  • 2.Anticipated to require ICU care beyond the next calendar day
  • 3.Hb less than 100 g/L at any time during the preceding 24 hours
  • 4.Age 18 years or greater

排除标准

  • 1.Suspected or confirmed severe sepsis (two or more Systemic Inflammatory Response Syndrome (SIRS) criteria, suspected or confirmed infection, and one or more organ system failure)
  • 2.Serum ferritin greater than 1200ng/ml or transferrin saturation greater than 50%
  • 3.History of haemochromatosis or aceruloplasminaemia
  • 4.Known prior administration of IV iron in the preceding 3 months
  • 5.Jehovah’s Witness or other documented exclusion to receiving blood products
  • 6.Receiving ESA (e.g. epoetin or darbepoeitin) in the 3 months prior to ICU admission
  • 7.Known hypersensitivity to intravenous iron
  • 8.Pregnancy
  • 9.Treatment intent is palliative
  • 10.Death is deemed imminent and inevitable
  • 11.Weight less than 40kg
  • 12.Participating in competing study

研究者

发起方
Edward Litton

相似试验